BCL6 and systemic lupus erythematosus: Overall, we provided supporting evidence that BCL-6 is a novel factor participating in the pathogenesis of lupus by epigenetically suppressing miR-142-3p/5p expression with the help of EZH2 in CD4+ T cells.